Angiotensin-II-receptor antagonists seem to be as effective as ACE inhibitors for treating hypertension and can be initiated in patients who are unable to tolerate an ACE inhibitor. All available ...

Candesartan cilexetil (Atacand, Astra Merck), another long-acting nonpeptide antagonist of AT-II type 1 receptors, is a prodrug that is hydrolyzed to its active metabolite candesartan during ...

Humanwell Healthcare (Group) Co. Ltd. has developed new heterocyclic compounds acting as angiotensin AT2 receptor antagonists reported to be useful for the treatment of neuropathy and neuropathic pain ...

Abstract The purpose of this study was to assess the inhibitory effect of TCV-116, an orally active angiotensin II (Ang II ... TCV-116, a new AT 1 receptor antagonist, and its active metabolite ...

Twitch is trying to crack down on viewers who use ad blockers with new prompts urging them to get Turbo instead. Just like YouTube before them, Twitch is now taking drastic action to get users to ...

One way or another, beta blockers are always in the news ... the medicine could be developed by "applying basic knowledge of receptor-driven cell-signalling systems to clinical problems." ...

Department of Preclinical Imaging and Radiopharmacy, University of Tuebingen, Roentgenweg 1372076Tuebingen, Germany ...

As the name suggests, puberty blockers stop puberty from happening. These medications were originally invented to treat children who start puberty at an abnormally early age. They have been used ...

A continuation strategy of renin-angiotensin system inhibitors (RASIs) before major noncardiac surgery was associated with better post-operative outcomes than discontinuation, based on results from ...

Less than 0.1% of adolescents with private insurance in the United States are transgender or gender-diverse and are prescribed puberty blockers or gender-affirming hormones, according to the findings ...